健壮笑阳
Lv31
206 积分
2024-12-16 加入
-
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
7小时前
已完结
-
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
23天前
已完结
-
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
23天前
已完结
-
A randomized, double-blind, placebo-controlled, multi-center, phase III clinical trial to investigate silodosin in the treatment of benign prostatic hyperplasia
1个月前
已完结
-
Assessment of micafungin dosage regimens against Candida spp. in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation
1个月前
已完结
-
An update on drug–drug interactions associated with proton pump inhibitors
3个月前
已完结
-
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
3个月前
已完结
-
Systemic and Local Pharmacokinetics of DARE-BV1, a Novel Single Dose 2% Clindamycin Phosphate Vaginal Gel for the Treatment of Bacterial Vaginosis
4个月前
已完结
-
Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay
4个月前
已完结
-
Integrated Population Pharmacokinetics of Daprodustat in Patients with Chronic Kidney Disease with Anemia
4个月前
已完结